Predictive model of bosentan-induced liver toxicity in Japanese patients with pulmonary arterial hyp...
Predictive model of bosentan-induced liver toxicity in Japanese patients with pulmonary arterial hypertension1
About this item
Full title
Author / Creator
Publisher
1840 Woodward Drive, Suite 1, Ottawa, ON K2C 0P7: NRC Research Press
Journal title
Language
English
Formats
Publication information
Publisher
1840 Woodward Drive, Suite 1, Ottawa, ON K2C 0P7: NRC Research Press
Subjects
More information
Scope and Contents
Contents
Bosentan, an endothelin receptor antagonist, has been widely used as a first-line medication for the treatment of pulmonary arterial hypertension (PAH). It has been shown to improve symptoms of hypertension, exercise capacity, and hemodynamics and prolong time to clinical worsening. However, liver dysfunction is a major side effect of bosentan trea...
Alternative Titles
Full title
Predictive model of bosentan-induced liver toxicity in Japanese patients with pulmonary arterial hypertension1
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_nrcresearch_primary_10_1139_cjpp_2019_0656
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_nrcresearch_primary_10_1139_cjpp_2019_0656
Other Identifiers
ISSN
0008-4212
E-ISSN
1205-7541
DOI
10.1139/cjpp-2019-0656
